Skip to main content

Autoimmune Disorder Drug Delivery Devices Market to Witness Huge Growth by 2020-2030

Healthcare experts have found the autoimmune disorders industry to be one of the most rapidly evolving markets. The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030. The market is driven by certain factors, including the increasing global geriatric population, increasing incidence of chronic diseases including autoimmune disorders, and rise in demand for self-injectable systems.

The market is favored by the development of autoimmune disorder drug delivery devices for several clinical areas such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and psoriasis. The increase in the geriatric population and incurable autoimmune disorders across the globe are expected to translate into a significantly higher demand for autoimmune disorder drug delivery devices.

Furthermore, the companies are investing huge amounts in research and development of autoimmune disorder drug delivery devices. The clinical trial landscape of different autoimmune disorders has been on the rise in recent years, and this will drive the autoimmune disorder drug delivery devices market in the future.

Within the research report, the market is segmented based on indication, product type, manufacturing type, and region. Each of these segments covers the market’s snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained

View Report - https://bisresearch.com/industry-report/autoimmune-disorder-drug-delivery-devices-market.html

 Market Segmentation

•    Indication – Systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and psoriasis

•    Product Type – Pen injectors, auto-injectors, pre-filled syringes, and vials

•    Manufacturing Type – In-house manufacturing and outsourced manufacturing


Regional Segmentation

•    North America – U.S., Canada

•    Europe – Germany, France, Italy, U.K., Spain, Russia, and Rest-of-Europe

•    Asia-Pacific – China, Japan, India, Taiwan, South Korea, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)

•    Latin America – Brazil, Mexico, and Rest-of-the-Latin America

•    Rest-of-the-World


Growth Drivers

•    Increased Prevalence of Autoimmune Disorders

•    Technological Advancements in the Field of Pre-Filled Syringes

•    Rising Geriatric Population

•    Surge of Biosimilars and Biologics in the Pharmaceutical Market

•    Device Connectivity to Ease Competitive Pressure


Market Challenges

•    Strict Legal Requirements and Regulations

•    Alternative Drug Delivery Technology


Market Opportunities

•    Providing Injectable Drug Delivery Devices for Untapped Autoimmune Disorders

•    Opportunities of Personalizing Treatments in Autoimmune Diseases


Key Companies Profiled

AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Bristol Myers Squibb Company, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., UCB Inc., and Takeda Pharmaceutical Company Limited, among others.

Request a Sample- https://bisresearch.com/requestsample?id=1010&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more

PP Compound Market for Automotive Industry expected to grow at CAGR of 5.6%

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Growth of PP Compound Market for the A utomotive   Industry Polypropylene compounds are a kind of resin made from a mixture of one or more base polyolefins. This compound is the base resin that is then mixed with different pigments and additives, which alter the characteristics of the products accordingly depending on the intended use. These polypropylene compounds offer varied applications such as electrical appliances, automotive, building and construction, and furniture components.   Benefits of PP Compound Polypropylene can provide some great benefits to manufacturers who use auxiliary parts of cars   . For instance, if the ...
Post a Comment
Read more